Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms

被引:0
|
作者
MM Kennedy
D Lamb
G King
KM Kerr
机构
[1] Aberdeen University Medical School,Department of Pathology
来源
British Journal of Cancer | 1997年 / 75卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Immunohistochemical staining of bcl-2 and p53 proteins was compared with thymidine labelling index (TLI) and cell loss factor (O) in lung cancer. Neither bcl-2 nor p53 overexpression was associated with high cell loss but strong bcl-2 staining was associated with higher TLI. Concomitant strong p53 and bcl-2 expression, not the usual inverse relationship, plus high cell-loss factor was present in three neuroendocrine carcinomas. Other factors presumably have a role in controlling cell death in these tumours.
引用
收藏
页码:545 / 547
页数:2
相关论文
共 50 条
  • [41] Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression
    Basolo, F
    Pollina, L
    Fontanini, G
    Fiore, L
    Pacini, F
    Baldanzi, A
    BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 537 - 541
  • [42] Depth of infiltration of primary gastric B-cell lymphomas - Correlations with proliferation, apoptosis and expression of p53 and bcl-2
    Eidt, S
    Lorenzen, J
    Ortmann, M
    PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (09) : 925 - 930
  • [43] Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers
    Chan, WY
    Cheung, KK
    Schorge, JO
    Huang, LW
    Welch, WR
    Bell, DA
    Berkowitz, RS
    Mok, SC
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02): : 409 - 417
  • [44] p53 gene mutation bcl-2 expression and apoptisis in human gliomas
    Liu, AX
    Pu, PY
    Cheng, AG
    JOURNAL OF NEUROCHEMISTRY, 1996, 67 : S38 - S38
  • [45] Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas
    Li, Yin
    Xu, Ke-Ping
    Jiang, Dong
    Zhao, Jun
    Ge, Jin-Feng
    Zheng, Shi-Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 13978 - 13986
  • [46] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
  • [47] HETEROGENEITY IN CELL-PROLIFERATION AND EXPRESSION OF P53 AND BCL-2 DURING THE INDOLENT PHASE OF GERMINAL CENTER CELL LYMPHOMA - AN EXPLANATION FOR CLINICAL VARIABILITY
    BARRANS, S
    RANDERSON, J
    EVANS, P
    BLYTHE, D
    SHIACH, C
    CHILD, JA
    MORGAN, G
    JACK, AS
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (04) : 830 - 836
  • [48] The p53–Bcl-2 connection
    M T Hemann
    S W Lowe
    Cell Death & Differentiation, 2006, 13 : 1256 - 1259
  • [49] bcl-2, p53 immunophenotypes and apoptosis in squamous cell carcinoma of the oesophagus
    Sur, M
    Cooper, K
    HISTOPATHOLOGY, 1998, 33 (01) : 87 - 88
  • [50] COMPARATIVE EXPRESSION OF BCL-2 AND P53 IN ESTHESIONEUROBLASTOMAS AND RETINOBLASTOMAS
    MUNOZ, EL
    LOTANO, MA
    LEVINE, P
    LOPES, MBS
    GONZALEZFERNANDEZ, F
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (03): : 424 - 424